These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8974479)
1. [Biochemical and physiological activity of new peptide inhibitors of angiotensin-converting enzyme]. Gomazkov OA; Pozdnev VF; Kalinina EV; Komissarova NV; Medvedeva NA; Nesterova MA; Petriĭ OP Biull Eksp Biol Med; 1996 Sep; 122(9):279-81. PubMed ID: 8974479 [No Abstract] [Full Text] [Related]
2. Synthesis and antienzymic activity of two new angiotensin converting enzyme inhibitors. Dudkiewicz J; Suska T; Tautt J; Paruszewski R Pol J Pharmacol Pharm; 1991; 43(1):33-8. PubMed ID: 1663247 [TBL] [Abstract][Full Text] [Related]
3. Prolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors. Ciabatti R; Tarzia G; Battaglia F; Barone D; Baldoli E Farmaco Sci; 1988 Dec; 43(12):989-1003. PubMed ID: 2854788 [TBL] [Abstract][Full Text] [Related]
4. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme). Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975 [TBL] [Abstract][Full Text] [Related]
6. [Synthesis of angiotensin converting enzyme inhibitors containing residues of substituted quinolines and a study of their biological activity]. Filatova MP; Krit NA; Uskova NN; Maksimova EM; Gracheva IN; Reĭssmann Z Bioorg Khim; 1991 May; 17(5):690-6. PubMed ID: 1662954 [TBL] [Abstract][Full Text] [Related]
7. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors? Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875 [TBL] [Abstract][Full Text] [Related]
8. [Effect of captopril on angiotensin-converting enzyme activity and animal behavior in the "open field" test]. Vernigora AN; Gengin MT; Nikishin NN; Shchetinina NV Vopr Med Khim; 1996; 42(1):34-8. PubMed ID: 8999656 [TBL] [Abstract][Full Text] [Related]
9. Effect of cadmium and captopril on serum angiotensin converting enzyme activity in rats. Puri VN Indian Heart J; 1997; 49(3):297-9. PubMed ID: 9291654 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril. Udupa EG; Rao NM Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434 [TBL] [Abstract][Full Text] [Related]
11. Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats. Crespo MJ; Dunbar DC Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1311-8. PubMed ID: 14984003 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme in bovine, feline, and human ocular tissues. Ferrari-Dileo G; Ryan JW; Rockwood EJ; Davis EB; Anderson DR Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):876-81. PubMed ID: 2836331 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of oral trandolapril and enalapril on rat tissue angiotensin-converting enzyme. Chevillard C; Brown NL; Mathieu MN; Laliberté F; Worcel M Eur J Pharmacol; 1988 Feb; 147(1):23-8. PubMed ID: 2836219 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia. Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881 [TBL] [Abstract][Full Text] [Related]
15. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors. Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850 [TBL] [Abstract][Full Text] [Related]
17. Distribution of angiotensin converting enzyme in sheep hypothalamus and medulla oblongata visualized by in vitro autoradiography. Chai SY; McKinley MJ; Mendelsohn FA Clin Exp Hypertens A; 1987; 9(2-3):449-60. PubMed ID: 3038409 [TBL] [Abstract][Full Text] [Related]
18. [The interconnection between the activity of carboxypeptidase N and angiotensin-converting enzyme]. Vernigora AN; Nikishin NN; Gengin MT Biokhimiia; 1995 Jan; 60(1):144-9. PubMed ID: 7696431 [TBL] [Abstract][Full Text] [Related]
19. Correlation between ACE activity and mean blood pressure in Iranian normotensive subjects after oral administration of a single dose of enalapril. Ziai SA; Seyedhosseini D; Taiebi L; Salekmoghadam E; Mahmoudian M Acta Physiol Hung; 2000; 87(2):153-9. PubMed ID: 11205963 [TBL] [Abstract][Full Text] [Related]
20. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme. Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]